The Methenamine Hippurate Tablets, cataloged under National Stock Number 6505-00-126-3207, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Aventis Pharmaceuticals Products Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 7 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-126-3207 |
| Primary Part Number | NDC00068-0277-61 |
| Item Name | Methenamine Hippurate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Aventis Pharmaceuticals Products Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 1.000 GRAMS METHENAMINE HIPPURATE ACTIVE INGREDIENT G |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00068-0277-61 PRIMARY | Aventis Pharmaceuticals Products Inc. (USA) |
| NDC65199-1201-01 | Vatring Pharmaceuticals, Inc. (USA) |
| Reference | Meaning |
|---|---|
| HIPREX | 5/9 Secondary reference Merrell Dow Pharmeceuticals Inc Bids and Contracts Dept |
| UREX TABLETS | 5/9 Secondary reference 3m Company Health Care/mfg |
| UREX | 5/9 Secondary reference 3m Company Health Care/mfg |
| HIPREX TABLETS | 5/9 Secondary reference Merrell Dow Pharmeceuticals Inc Bids and Contracts Dept |
| UREX | 5/1 Secondary reference Vatring Pharmaceuticals, Inc. |
| NDC00089-0371-10 | 5/9 Secondary reference 3m Company Health Care/mfg |
| NDC00068-0277-61 | 5/9 Secondary reference Merrell Dow Pharmeceuticals Inc Bids and Contracts Dept |
NSN 6505-00-126-3207 is a Methenamine Hippurate Tablets, manufactured by Aventis Pharmaceuticals Products Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-126-3207 has 2 manufacturer part numbers on file: NDC00068-0277-61 (Aventis Pharmaceuticals Products Inc.), NDC65199-1201-01 (Vatring Pharmaceuticals, Inc.).
1 possible match (shared part number, not a government interchangeability claim): 6505-00-443-4501. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00068-0277-61: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: METHENAMINE HIPPURATE TABLETS USP 1 GM 100 TABLETS PER BOTTLE. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.